Last reviewed · How we verify
NCT03931395
Honey Used as Adjunct Therapy to Tylenol for Post-Op Tonsillectomy Patients
NA trial testing Honey in Tonsillectomy in 230 participants. Completed in 23 September 2020.
23 September 2020
Quick facts
| Lead sponsor | Vanderbilt University Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 230 |
| Start date | 16 April 2019 |
| Primary completion | 23 September 2020 |
| Estimated completion | 23 September 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Honey — full drug profile →
- Standard of Care
Conditions studied
- Tonsillectomy — all drugs for Tonsillectomy →
Sponsor
Vanderbilt University Medical Center
Who can join
Adults 2 to 17, any sex, with Tonsillectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Tonsillectomies are the second most common surgery with over half a million procedures in the United States for 2006. Tonsillectomies are considered a painful surgical procedure performed on children resulting in pain and nausea/vomiting for up to 7 days postoperatively. Up until recently, doctors have been prescribing upwards of ten days' worth of opioid pain medication for children following tonsillectomies due to the high incidence of pain expected afterwards. Effective July 1st, 2018, new laws regarding opioid restrictions came into place that restricted doctor's abilities to write for more than three days' worth of opioid pain medication without having to fill out sizeable amounts of additional paperwork. This law was put in place to combat the ongoing opioid epidemic that plagues this country. What the investigators are left with for the treatment of pain following these procedures are simply Tylenol and Motrin with a limited amount of opioid. With this being considered a highly painful surgery with a difficult recovery, more options are needed to effectively treat pain and reduce the incidence of emergency room visits and phone calls to the clinic regarding pain control in the postoperative period. Studies in Europe have shown that honey is an effective adjunct treatment option in the reduction of pain in pediatric postoperative tonsillectomies. These studies are few and far between and more research needs to be conducted to validate these claims particularly in the United States where research on this subject has been extremely limited. Further, the extent to which families and health care providers in the United States would be receptive to using honey for children's postoperative pain is unclear since honey is considered a complementary and alternative medicine (CAM) intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03931395
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Honey
Trials testing the same drug.
- NCT06562257 — Honey as A Wound Care Modality in Treating Deep Neck Space Abscess · NA · recruiting
- NCT06456060 — Efficacy of Pure Honey Dressing in Contrast to Alvogyl in the Resolution of Dry Socket · Phase 1 · recruiting
- NCT07144969 — Chewing Gum vs Honey in Postoperative Recovery After Ileostomy Reversal: A Study Comparing Their Effects on Bowel Functi · NA · completed
- NCT06107231 — WHNRC (Western Human Nutrition Research Center) Honey Study · NA · active not recruiting
- NCT05568563 — Comparison of Effectiveness of Pre-cooling With Ethyl Chloride Versus Honey · NA · completed
Other recruiting trials for Tonsillectomy
Currently open trials in the same condition.
- NCT07489742 — Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Tonsillectomy · NA · recruiting
- NCT07494370 — Adenoidectomy: Correlation Between Individual Factors, Surgical Technique, and Residual Adenoids · recruiting
- NCT03783182 — Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy · Phase 4 · recruiting
- NCT03625011 — Gabapentin Premedication to Reduce Postoperative Pain for Pediatric Tonsillectomy · Phase 4 · recruiting
Other Vanderbilt University Medical Center trials
Trials by the same sponsor.
- NCT07005037 — Swallowing Impairments in ICU Survivors and Community-Dwelling Adults · not yet recruiting
- NCT07527273 — Cognitive Enhancement in Recurrent Depression (The COG-D-R Study) · NA · not yet recruiting
- NCT07295288 — Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial Synkinesis · Phase 4 · not yet recruiting
- NCT07431541 — Topical Carboxytherapy Paste Following Microneedling · Phase 1, PHASE2 · not yet recruiting
- NCT07224711 — The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03931395 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vanderbilt University Medical Center
- Last refreshed: 1 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03931395.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing